Feasibility Trial of Electroacupuncture for Aromatase Inhibitor—Related Arthralgia in Breast Cancer Survivors
Identifieur interne : 006659 ( Main/Exploration ); précédent : 006658; suivant : 006660Feasibility Trial of Electroacupuncture for Aromatase Inhibitor—Related Arthralgia in Breast Cancer Survivors
Auteurs : James J. Mao [États-Unis] ; Deborah W. Bruner [États-Unis] ; Carrie Stricker [États-Unis] ; John T. Farrar [États-Unis] ; Sharon X. Xie [États-Unis] ; Marjorie A. Bowman [États-Unis] ; Donna Pucci [États-Unis] ; Donna Xiaoyan Han [États-Unis] ; Angela Demichele [États-Unis]Source :
- Integrative Cancer Therapies [ 1534-7354 ] ; 2009-06.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Amplitude articulaire, Anxiété (), Anxiété (étiologie), Arthralgie (), Dyssomnies (), Dyssomnies (étiologie), Dépression (), Dépression (étiologie), Fatigue (), Fatigue (étiologie), Femelle, Humains, Inhibiteurs de l'aromatase (effets indésirables), Inhibiteurs de l'aromatase (usage thérapeutique), Résultat thérapeutique, Sujet âgé, Survivants, Tumeurs du sein (), Tumeurs du sein (traitement médicamenteux), Électroacupuncture (), Électroacupuncture (effets indésirables), Études de faisabilité.
- MESH :
- effets indésirables : Inhibiteurs de l'aromatase, Électroacupuncture.
- traitement médicamenteux : Tumeurs du sein.
- usage thérapeutique : Inhibiteurs de l'aromatase.
- étiologie : Anxiété, Dyssomnies, Dépression, Fatigue.
- Adulte d'âge moyen, Amplitude articulaire, Anxiété, Arthralgie, Dyssomnies, Dépression, Fatigue, Femelle, Humains, Résultat thérapeutique, Sujet âgé, Survivants, Tumeurs du sein, Électroacupuncture, Études de faisabilité.
English descriptors
- KwdEn :
- Aged, Anxiety (etiology), Anxiety (therapy), Aromatase Inhibitors (adverse effects), Aromatase Inhibitors (therapeutic use), Arthralgia (chemically induced), Arthralgia (complications), Arthralgia (therapy), Breast Neoplasms (complications), Breast Neoplasms (drug therapy), Depression (etiology), Depression (therapy), Dyssomnias (etiology), Dyssomnias (therapy), Electroacupuncture (adverse effects), Electroacupuncture (methods), Fatigue (etiology), Fatigue (therapy), Feasibility Studies, Female, Humans, Middle Aged, Range of Motion, Articular, Survivors, Treatment Outcome.
- MESH :
- chemical , adverse effects : Aromatase Inhibitors.
- adverse effects : Electroacupuncture.
- chemically induced : Arthralgia.
- complications : Arthralgia, Breast Neoplasms.
- drug therapy : Breast Neoplasms.
- etiology : Anxiety, Depression, Dyssomnias, Fatigue.
- methods : Electroacupuncture.
- chemical , therapeutic use : Aromatase Inhibitors.
- therapy : Anxiety, Arthralgia, Depression, Dyssomnias, Fatigue.
- Aged, Feasibility Studies, Female, Humans, Middle Aged, Range of Motion, Articular, Survivors, Treatment Outcome.
Abstract
Background. Arthralgia affects postmenopausal women receiving aromatase inhibitors (AIs) for breast cancer. Given the existing evidence for electroacupuncture (EA) for treatment of osteoarthritis in the general population, this study aims to establish the feasibility of studying EA for treating AI-related arthralgia. Patients and Methods. Postmenopausal women with stage I-III breast cancer who reported AI-related arthral gia were enrolled in a single-arm feasibility trial. EA was provided twice a week for 2 weeks followed by 6 weekly treatments. The protocol was based on Chinese medicine diagnosis of “Bi” syndrome with electrostimulation of needles around the painful joint(s). Pain severity of the modified Brief Pain Inventory was used as the primary outcome. Joint stiffness, joint interference, and Patient Global Impression of Change (PGIC) were secondary outcomes. Paired t tests were used for analysis. Results. Twelve women were enrolled and all provided data for analysis. From baseline to the end of intervention, patients reported reduction in pain severity (from 5.3 to 1.9), stiffness (from 6.9 to 2.4), and joint symptom interference (from 4.7 to 0.8), all P < .001; 11/12 considered joint symptoms “very much better” based on the PGIC. Subjects also reported significant decrease in fatigue (from 4.4 to 1.9, P = .005) and anxiety (from 7.1 to 4.8, P = .01). No infection or development or worsening of lymphedema was observed. Conclusion. Preliminary data establish the feasibility of recruitment and acceptance as well as promising preliminary safety and effectiveness. A randomized controlled trial is warranted to establish the efficacy of EA for AI-related arthralgia in breast cancer survivors.
Url:
- https://api.istex.fr/document/8BD9F331CD4F260D651636CA40BC6E64DE1410BB/fulltext/pdf
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569528
DOI: 10.1177/1534735409332903
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 004185
- to stream Istex, to step Curation: 004185
- to stream Istex, to step Checkpoint: 000D99
- to stream Pmc, to step Corpus: 003464
- to stream Pmc, to step Curation: 003463
- to stream Pmc, to step Checkpoint: 003734
- to stream PubMed, to step Corpus: 002D81
- to stream PubMed, to step Curation: 002D81
- to stream PubMed, to step Checkpoint: 002D81
- to stream Ncbi, to step Merge: 003562
- to stream Ncbi, to step Curation: 003562
- to stream Ncbi, to step Checkpoint: 003562
- to stream Main, to step Merge: 006737
- to stream Main, to step Curation: 006659
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Feasibility Trial of Electroacupuncture for Aromatase Inhibitor—Related Arthralgia in Breast Cancer Survivors</title><author wicri:is="90%"><name sortKey="Mao, James J" sort="Mao, James J" uniqKey="Mao J" first="James J." last="Mao">James J. Mao</name></author><author wicri:is="90%"><name sortKey="Bruner, Deborah W" sort="Bruner, Deborah W" uniqKey="Bruner D" first="Deborah W." last="Bruner">Deborah W. Bruner</name></author><author wicri:is="90%"><name sortKey="Stricker, Carrie" sort="Stricker, Carrie" uniqKey="Stricker C" first="Carrie" last="Stricker">Carrie Stricker</name></author><author wicri:is="90%"><name sortKey="Farrar, John T" sort="Farrar, John T" uniqKey="Farrar J" first="John T." last="Farrar">John T. Farrar</name></author><author wicri:is="90%"><name sortKey="Xie, Sharon X" sort="Xie, Sharon X" uniqKey="Xie S" first="Sharon X." last="Xie">Sharon X. Xie</name></author><author wicri:is="90%"><name sortKey="Bowman, Marjorie A" sort="Bowman, Marjorie A" uniqKey="Bowman M" first="Marjorie A." last="Bowman">Marjorie A. Bowman</name></author><author wicri:is="90%"><name sortKey="Pucci, Donna" sort="Pucci, Donna" uniqKey="Pucci D" first="Donna" last="Pucci">Donna Pucci</name></author><author wicri:is="90%"><name sortKey="Xiaoyan Han, Donna" sort="Xiaoyan Han, Donna" uniqKey="Xiaoyan Han D" first="Donna" last="Xiaoyan Han">Donna Xiaoyan Han</name></author><author wicri:is="90%"><name sortKey="Demichele, Angela" sort="Demichele, Angela" uniqKey="Demichele A" first="Angela" last="Demichele">Angela Demichele</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:8BD9F331CD4F260D651636CA40BC6E64DE1410BB</idno><date when="2009" year="2009">2009</date><idno type="doi">10.1177/1534735409332903</idno><idno type="url">https://api.istex.fr/document/8BD9F331CD4F260D651636CA40BC6E64DE1410BB/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">004185</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">004185</idno><idno type="wicri:Area/Istex/Curation">004185</idno><idno type="wicri:Area/Istex/Checkpoint">000D99</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000D99</idno><idno type="wicri:doubleKey">1534-7354:2009:Mao J:feasibility:trial:of</idno><idno type="wicri:source">PMC</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569528</idno><idno type="RBID">PMC:3569528</idno><idno type="wicri:Area/Pmc/Corpus">003464</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">003464</idno><idno type="wicri:Area/Pmc/Curation">003463</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">003463</idno><idno type="wicri:Area/Pmc/Checkpoint">003734</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">003734</idno><idno type="wicri:source">PubMed</idno><idno type="wicri:Area/PubMed/Corpus">002D81</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002D81</idno><idno type="wicri:Area/PubMed/Curation">002D81</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002D81</idno><idno type="wicri:Area/PubMed/Checkpoint">002D81</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002D81</idno><idno type="wicri:Area/Ncbi/Merge">003562</idno><idno type="wicri:Area/Ncbi/Curation">003562</idno><idno type="wicri:Area/Ncbi/Checkpoint">003562</idno><idno type="wicri:doubleKey">1534-7354:2009:Mao J:feasibility:trial:of</idno><idno type="wicri:Area/Main/Merge">006737</idno><idno type="wicri:Area/Main/Curation">006659</idno><idno type="wicri:Area/Main/Exploration">006659</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Feasibility Trial of Electroacupuncture for Aromatase Inhibitor—Related Arthralgia in Breast Cancer Survivors</title><author wicri:is="90%"><name sortKey="Mao, James J" sort="Mao, James J" uniqKey="Mao J" first="James J." last="Mao">James J. Mao</name><affiliation></affiliation><affiliation wicri:level="1"><country wicri:rule="url">États-Unis</country></affiliation></author><author wicri:is="90%"><name sortKey="Bruner, Deborah W" sort="Bruner, Deborah W" uniqKey="Bruner D" first="Deborah W." last="Bruner">Deborah W. Bruner</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Pennsylvanie</region></placeName><wicri:cityArea>Abramson Cancer Center, University of Pennsylvania Health System, Philadelphia</wicri:cityArea></affiliation></author><author wicri:is="90%"><name sortKey="Stricker, Carrie" sort="Stricker, Carrie" uniqKey="Stricker C" first="Carrie" last="Stricker">Carrie Stricker</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Pennsylvanie</region></placeName><wicri:cityArea>Department of Medicine University of Pennsylvania Health System, Philadelphia, Pennsylvania, Abramson Cancer Center, University of Pennsylvania Health System, Philadelphia</wicri:cityArea></affiliation></author><author wicri:is="90%"><name sortKey="Farrar, John T" sort="Farrar, John T" uniqKey="Farrar J" first="John T." last="Farrar">John T. Farrar</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Pennsylvanie</region></placeName><wicri:cityArea>Abramson Cancer Center, University of Pennsylvania Health System, Philadelphia, Pennsylvania, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Health System, Philadelphia</wicri:cityArea></affiliation></author><author wicri:is="90%"><name sortKey="Xie, Sharon X" sort="Xie, Sharon X" uniqKey="Xie S" first="Sharon X." last="Xie">Sharon X. Xie</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Pennsylvanie</region></placeName><wicri:cityArea>Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Health System, Philadelphia</wicri:cityArea></affiliation></author><author wicri:is="90%"><name sortKey="Bowman, Marjorie A" sort="Bowman, Marjorie A" uniqKey="Bowman M" first="Marjorie A." last="Bowman">Marjorie A. Bowman</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Pennsylvanie</region></placeName><wicri:cityArea>Department of Family Medicine and Community Health, University of Pennsylvania Health System, Philadelphia</wicri:cityArea></affiliation></author><author wicri:is="90%"><name sortKey="Pucci, Donna" sort="Pucci, Donna" uniqKey="Pucci D" first="Donna" last="Pucci">Donna Pucci</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Pennsylvanie</region></placeName><wicri:cityArea>Abramson Cancer Center, University of Pennsylvania Health System, Philadelphia</wicri:cityArea></affiliation></author><author wicri:is="90%"><name sortKey="Xiaoyan Han, Donna" sort="Xiaoyan Han, Donna" uniqKey="Xiaoyan Han D" first="Donna" last="Xiaoyan Han">Donna Xiaoyan Han</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Pennsylvanie</region></placeName><wicri:cityArea>Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Health System, Philadelphia</wicri:cityArea></affiliation></author><author wicri:is="90%"><name sortKey="Demichele, Angela" sort="Demichele, Angela" uniqKey="Demichele A" first="Angela" last="Demichele">Angela Demichele</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Pennsylvanie</region></placeName><wicri:cityArea>Department of Medicine, University of Pennsylvania Health System, Philadelphia, Pennsylvania, Abramson Cancer Center, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Health System, Philadelphia</wicri:cityArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Integrative Cancer Therapies</title><idno type="ISSN">1534-7354</idno><idno type="eISSN">1552-695X</idno><imprint><publisher>SAGE Publications</publisher><pubPlace>Sage CA: Los Angeles, CA</pubPlace><date type="published" when="2009-06">2009-06</date><biblScope unit="volume">8</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="123">123</biblScope><biblScope unit="page" to="129">129</biblScope></imprint><idno type="ISSN">1534-7354</idno></series><idno type="istex">8BD9F331CD4F260D651636CA40BC6E64DE1410BB</idno><idno type="DOI">10.1177/1534735409332903</idno><idno type="ArticleID">10.1177_1534735409332903</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1534-7354</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Anxiety (etiology)</term><term>Anxiety (therapy)</term><term>Aromatase Inhibitors (adverse effects)</term><term>Aromatase Inhibitors (therapeutic use)</term><term>Arthralgia (chemically induced)</term><term>Arthralgia (complications)</term><term>Arthralgia (therapy)</term><term>Breast Neoplasms (complications)</term><term>Breast Neoplasms (drug therapy)</term><term>Depression (etiology)</term><term>Depression (therapy)</term><term>Dyssomnias (etiology)</term><term>Dyssomnias (therapy)</term><term>Electroacupuncture (adverse effects)</term><term>Electroacupuncture (methods)</term><term>Fatigue (etiology)</term><term>Fatigue (therapy)</term><term>Feasibility Studies</term><term>Female</term><term>Humans</term><term>Middle Aged</term><term>Range of Motion, Articular</term><term>Survivors</term><term>Treatment Outcome</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Amplitude articulaire</term><term>Anxiété ()</term><term>Anxiété (étiologie)</term><term>Arthralgie ()</term><term>Dyssomnies ()</term><term>Dyssomnies (étiologie)</term><term>Dépression ()</term><term>Dépression (étiologie)</term><term>Fatigue ()</term><term>Fatigue (étiologie)</term><term>Femelle</term><term>Humains</term><term>Inhibiteurs de l'aromatase (effets indésirables)</term><term>Inhibiteurs de l'aromatase (usage thérapeutique)</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Survivants</term><term>Tumeurs du sein ()</term><term>Tumeurs du sein (traitement médicamenteux)</term><term>Électroacupuncture ()</term><term>Électroacupuncture (effets indésirables)</term><term>Études de faisabilité</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Aromatase Inhibitors</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Electroacupuncture</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Arthralgia</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Arthralgia</term><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Inhibiteurs de l'aromatase</term><term>Électroacupuncture</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Anxiety</term><term>Depression</term><term>Dyssomnias</term><term>Fatigue</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Electroacupuncture</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Aromatase Inhibitors</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Anxiety</term><term>Arthralgia</term><term>Depression</term><term>Dyssomnias</term><term>Fatigue</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Inhibiteurs de l'aromatase</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Anxiété</term><term>Dyssomnies</term><term>Dépression</term><term>Fatigue</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Feasibility Studies</term><term>Female</term><term>Humans</term><term>Middle Aged</term><term>Range of Motion, Articular</term><term>Survivors</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Amplitude articulaire</term><term>Anxiété</term><term>Arthralgie</term><term>Dyssomnies</term><term>Dépression</term><term>Fatigue</term><term>Femelle</term><term>Humains</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Survivants</term><term>Tumeurs du sein</term><term>Électroacupuncture</term><term>Études de faisabilité</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Background. Arthralgia affects postmenopausal women receiving aromatase inhibitors (AIs) for breast cancer. Given the existing evidence for electroacupuncture (EA) for treatment of osteoarthritis in the general population, this study aims to establish the feasibility of studying EA for treating AI-related arthralgia. Patients and Methods. Postmenopausal women with stage I-III breast cancer who reported AI-related arthral gia were enrolled in a single-arm feasibility trial. EA was provided twice a week for 2 weeks followed by 6 weekly treatments. The protocol was based on Chinese medicine diagnosis of “Bi” syndrome with electrostimulation of needles around the painful joint(s). Pain severity of the modified Brief Pain Inventory was used as the primary outcome. Joint stiffness, joint interference, and Patient Global Impression of Change (PGIC) were secondary outcomes. Paired t tests were used for analysis. Results. Twelve women were enrolled and all provided data for analysis. From baseline to the end of intervention, patients reported reduction in pain severity (from 5.3 to 1.9), stiffness (from 6.9 to 2.4), and joint symptom interference (from 4.7 to 0.8), all P < .001; 11/12 considered joint symptoms “very much better” based on the PGIC. Subjects also reported significant decrease in fatigue (from 4.4 to 1.9, P = .005) and anxiety (from 7.1 to 4.8, P = .01). No infection or development or worsening of lymphedema was observed. Conclusion. Preliminary data establish the feasibility of recruitment and acceptance as well as promising preliminary safety and effectiveness. A randomized controlled trial is warranted to establish the efficacy of EA for AI-related arthralgia in breast cancer survivors.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Pennsylvanie</li></region></list><tree><country name="États-Unis"><noRegion><name sortKey="Mao, James J" sort="Mao, James J" uniqKey="Mao J" first="James J." last="Mao">James J. Mao</name></noRegion><name sortKey="Bowman, Marjorie A" sort="Bowman, Marjorie A" uniqKey="Bowman M" first="Marjorie A." last="Bowman">Marjorie A. Bowman</name><name sortKey="Bruner, Deborah W" sort="Bruner, Deborah W" uniqKey="Bruner D" first="Deborah W." last="Bruner">Deborah W. Bruner</name><name sortKey="Demichele, Angela" sort="Demichele, Angela" uniqKey="Demichele A" first="Angela" last="Demichele">Angela Demichele</name><name sortKey="Farrar, John T" sort="Farrar, John T" uniqKey="Farrar J" first="John T." last="Farrar">John T. Farrar</name><name sortKey="Pucci, Donna" sort="Pucci, Donna" uniqKey="Pucci D" first="Donna" last="Pucci">Donna Pucci</name><name sortKey="Stricker, Carrie" sort="Stricker, Carrie" uniqKey="Stricker C" first="Carrie" last="Stricker">Carrie Stricker</name><name sortKey="Xiaoyan Han, Donna" sort="Xiaoyan Han, Donna" uniqKey="Xiaoyan Han D" first="Donna" last="Xiaoyan Han">Donna Xiaoyan Han</name><name sortKey="Xie, Sharon X" sort="Xie, Sharon X" uniqKey="Xie S" first="Sharon X." last="Xie">Sharon X. Xie</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006659 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 006659 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:8BD9F331CD4F260D651636CA40BC6E64DE1410BB
|texte= Feasibility Trial of Electroacupuncture for Aromatase Inhibitor—Related Arthralgia in Breast Cancer Survivors
}}
| This area was generated with Dilib version V0.6.31. |  |